O Brien Greene & Co. Inc Purchases 25,000 Shares of The Joint Corp. (NASDAQ:JYNT)

O Brien Greene & Co. Inc raised its position in The Joint Corp. (NASDAQ:JYNT - Free Report) by 20.9% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 144,620 shares of the company's stock after acquiring an additional 25,000 shares during the period. O Brien Greene & Co. Inc owned approximately 0.97% of Joint worth $1,537,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of JYNT. Los Angeles Capital Management LLC grew its holdings in shares of Joint by 13.4% during the third quarter. Los Angeles Capital Management LLC now owns 89,964 shares of the company's stock valued at $1,029,000 after buying an additional 10,641 shares during the last quarter. Verus Capital Partners LLC lifted its position in Joint by 5.9% in the 3rd quarter. Verus Capital Partners LLC now owns 132,955 shares of the company's stock valued at $1,521,000 after acquiring an additional 7,440 shares in the last quarter. Douglass Winthrop Advisors LLC boosted its stake in Joint by 4.1% during the 3rd quarter. Douglass Winthrop Advisors LLC now owns 146,400 shares of the company's stock valued at $1,675,000 after purchasing an additional 5,800 shares during the last quarter. FMR LLC increased its holdings in Joint by 38.0% during the 3rd quarter. FMR LLC now owns 10,787 shares of the company's stock worth $123,000 after purchasing an additional 2,971 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its holdings in Joint by 5.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company's stock worth $258,000 after purchasing an additional 1,156 shares in the last quarter. Institutional investors own 76.88% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on JYNT. Roth Mkm dropped their target price on Joint from $16.00 to $15.00 and set a "buy" rating on the stock in a report on Friday, November 8th. StockNews.com upgraded Joint from a "hold" rating to a "buy" rating in a research note on Friday, November 15th.

Joint Stock Performance

Shares of Joint stock traded down $0.01 during mid-day trading on Friday, hitting $11.35. 49,309 shares of the stock were exchanged, compared to its average volume of 34,186. The Joint Corp. has a 12 month low of $9.10 and a 12 month high of $17.82. The company has a 50-day simple moving average of $10.88 and a 200 day simple moving average of $11.21. The company has a market capitalization of $170.02 million, a P/E ratio of -9.96 and a beta of 1.60.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.